RAPAMUNE
RAPAMUNE
Approved
DIN Number
02243237
Drug Class
Human
Market Date
May 15, 2001
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243237
AIG Number0142721001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AH01 SIROLIMUS
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification90:28.24.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SIROLIMUSActive
Strength: 1 MG / ML
Monograph: SIROLIMUS